Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

FSD Pharma (HUGE) Stock Forecast & Price Target

FSD Pharma logo
Get the Latest News and Ratings for HUGE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for FSD Pharma and its competitors.

Sign Up

HUGE Analyst Ratings Over Time

TypeCurrent Forecast
11/23/23 to 11/22/24
1 Month Ago
10/24/23 to 10/23/24
3 Months Ago
8/25/23 to 8/24/24
1 Year Ago
11/23/22 to 11/23/23
Strong Buy N/A N/A N/A N/A
Buy N/A N/A N/A N/A
Hold N/A N/A N/A N/A
Sell N/A N/A N/A N/A
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingN/AN/AN/AN/A

HUGE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HUGE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

FSD Pharma Stock vs. The Competition

TypeFSD PharmaMedical CompaniesS&P 500
Consensus Rating Score
0.00
2.80
2.50
Consensus RatingN/AModerate BuyModerate Buy
Predicted UpsideN/A26,677.71% Upside8.53% Upside
News Sentiment Rating
Neutral News

See Recent HUGE News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/7/2024Singular Research
1 of 5 stars
B. Cook
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy-Venture

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:54 AM ET.



This page (NASDAQ:HUGE) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners